NCT04997005View on ClinicalTrials.gov

The Medacta International AMIStem-P Post-Marketing Surveillance Study

Active, not recruitingOBSERVATIONAL
Enrollment

550

Participants

Timeline

Start Date

April 26, 2019

Primary Completion Date

April 30, 2029

Study Completion Date

December 31, 2032

Conditions
ArthrosisTraumatic ArthritisRheumatoid PolyarthritisCongenital Hip DysplasiaAvascular Necrosis of the Femoral Head
Interventions
DEVICE

AMIStem-P

Performance of Total Hip Arthroplasty (THA) with AMIStem-P femoral stem implant

Trial Locations (5)

12000

Hôpital Jacques-Puel, Rodez

33270

Nouvelle Clinique Bordeaux Tondu, Floirac

62575

Clinique de Saint Omer, Blendecques

81108

Hôpital Castres, Castres

84100

Clinique d'Orange, Orange

Sponsors
All Listed Sponsors
lead

Medacta International SA

INDUSTRY